About Progeneron

Progeneron is a research company focusing on topically applied products for hand and skin diseases, disorders, syndromes, and conditions. Our team includes surgeons, physicians, chemists, and scientists led by Dr. David Scharp, MD. Our goal is to help in disease prevention, mitigation, and improvement through leading science and to increase awareness through published clinical data.

Clinical data, including studies, are available to physicians via our Progeneron Physician Portal and to the public, where applicable via the Scharp Lacy Research Institute, a 501(c)3 nonprofit that focuses on Diabetes, Stem Cell, and Dupuytren's research.


About Dr. Scharp 

Progeneron was created by Dr. David Scharp, MD, who trained, taught, and worked at Washington University School of Medicine, St. Louis, MO, for 30 years as a Professor of Surgery and researcher in islet transplantation. Dr. Scharp has produced over 200 peer-reviewed publications and has been cited over 9000 times. Dr. Scharp has been awarded numerous NIH (National Institutes of Health) and JDRF (Juvenile Diabetes Research Foundation) research grants. Dr. Scharp has 13 issued patents and has been the Chief Medical Officer of multiple companies specializing in clinical therapeutic solutions. Dr. Scharp is presently working on cosmetic and pharmaceutical products covering a broad range of treatment protocols, including Dupuytren's Contracture, because of his personal experience with the disease. 


To view Dr. Scharp’s complete CV, please click here.


Our Commitment 

  • Therapeutic skin solutions through scientific innovation.
  • Ingredients sourced specifically for potency and clinical efficacy. 
  • Safety through independent studies and testing.